- Home
- VPG vs HRTX Comparison
VPG vs HRTX Comparison
Compare VPG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VPG | HRTX |
|---|---|---|
| Founded | 2009 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.3M | 203.5M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | VPG | HRTX |
|---|---|---|
| Price | $37.94 | $1.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $44.00 | $4.50 |
| AVG Volume (30 Days) | 123.7K | ★ 2.1M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $299,283,000.00 | $155,097,000.00 |
| Revenue This Year | $0.48 | $8.98 |
| Revenue Next Year | $4.94 | $11.57 |
| P/E Ratio | $63.92 | ★ N/A |
| Revenue Growth | N/A | ★ 12.60 |
| 52 Week Low | $18.57 | $1.00 |
| 52 Week High | $39.86 | $2.68 |
Technical Indicators
Market Signals| Indicator | VPG | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 61.00 | 51.40 |
| Support Level | $37.64 | $1.13 |
| Resistance Level | $39.65 | $1.44 |
| Average True Range (ATR) | 1.57 | 0.09 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 76.52 | 47.22 |
Price Performance
Historical ComparisonAbout VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.